Medication Use in Pediatrics
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 August 2019) | Viewed by 4606
Special Issue Editors
Interests: pediatric pharmacotherapy; obesity; diabetes; ambulatory care services
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In pediatric pharmacotherapy, clinicians are often left to use case reports, case series, and retrospective reviews to determine the most efficacious and safe pharmacotherapy in pediatric patients. Despite federal legistlation, the lag time for pediatric-specific labeling for drugs approved for use in adults is approximately eight years. This lag time necessitates the use of medications off-lable. The intent of this Special Issue is to provide clinicians with data supporting or cautioning use of medications that may have limited data to optimize efficacious and safe pharmacotherapy in pediatrics.
We invite authors to share expeiences with medications in pediatric patients with limited data related to efficacy and safety. This may include experience with new dosing regimens, monitoring parameters, and pharmacokinetic or pharmacogenomic considerations. Our hope is that this Issue can contribute to and advance pediatric pharmacotherapy.
Prof. Dr. Sandra Benavides
Prof. Dr. Shirin Madzhidova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Pharmacotherapy
- Monitoring
- Pharmacogenomics
- Off-label
- Pediatric
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
